RA
GMED icon

Royce & Associates’s Globus Medical GMED Stock Holding History

Royce & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-363
Closed -$11K – 1253
2017
Q3 		$11K Buy
+363
New +$11.1K ﹤0.01% 1147
2013
Q4 		– Sell
-601,677
Closed -$10.5M – 1452
2013
Q3 		$10.5M Sell
601,677
-169,000
-22% -$2.92M 0.03% 635
2013
Q2 		$13M Buy
+770,677
New +$11.9M 0.04% 526

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Royce & Associates's GMED Position: Q4 2017 in Review

Royce & Associates sold out of Globus Medical (GMED) in Q4 2017, closing a stake of 363 shares — an estimated $11K sold.

Royce & Associates first reported a position in GMED in Q2 2013 and held it in 3 quarters. The position peaked at $13M in Q2 2013. 263 funds tracked by Wall St. Rank hold GMED as of Q4 2017.

  • Royce & Associates reported no remaining Globus Medical position as of Q4 2017 after selling out during the quarter.
  • Royce & Associates sold 363 Globus Medical shares in Q4 2017, an estimated $11K.
  • Royce & Associates first reported a position in Globus Medical in Q2 2013 and held it in 3 quarters.
  • Royce & Associates's Globus Medical position peaked at $13M in Q2 2013.
  • 263 funds tracked by Wall St. Rank held Globus Medical as of Q4 2017.

Based on Royce & Associates's 13F filing for Q4 2017, filed 9 Feb 2018.